Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 3,599,000 | 3,389,000 | 3,242,000 | 3,170,000 | 3,244,000 |
| Cost of Goods | 1,058,000 | 1,040,000 | 1,011,000 | 979,000 | 1,011,000 |
| Gross Profit | 2,542,000 | 2,349,000 | 2,232,000 | 2,191,000 | 2,233,000 |
| Operating Expenses | 2,027,000 | 1,798,000 | 1,830,000 | 1,833,000 | 1,811,000 |
| Operating Income | 514,000 | 552,000 | 402,000 | 358,000 | 423,000 |
| Interest Expense | 70,000 | 65,000 | 64,000 | 63,000 | 64,000 |
| Other Income | -18,000 | -43,000 | 57,000 | -50,000 | -14,000 |
| Pre-tax Income | 426,000 | 444,000 | 395,000 | 245,000 | 345,000 |
| Income Tax | 156,000 | 131,000 | 256,000 | 57,000 | 85,000 |
| Net Income Continuous | 270,000 | 313,000 | 139,000 | 188,000 | 260,000 |
| Net Income | $270,000 | $314,000 | $140,000 | $188,000 | $260,000 |
| EPS Basic Total Ops | 0.18 | 0.21 | 0.09 | 0.12 | 0.17 |
| EPS Basic Continuous Ops | 0.19 | 0.22 | 0.10 | 0.13 | 0.18 |
| EPS Diluted Total Ops | 0.18 | 0.21 | 0.09 | 0.12 | 0.17 |
| EPS Diluted Continuous Ops | 0.19 | 0.22 | 0.10 | 0.13 | 0.18 |
| EPS Diluted Before Non-Recurring Items | 0.53 | 0.47 | 0.45 | N/A | N/A |
| EBITDA(a) | $869,000 | $836,000 | $695,000 | $767,000 | $696,000 |